|
🐜
|
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.
11 auth.
V. Papadopoulos,
M. Baraldi,
T. Guilarte,
T. Knudsen,
J. Lacapere,
P. Lindemann,
...
M. Norenberg,
D. Nutt,
Abraham Weizman,
Ming-Rong Zhang,
M. Gavish
|
10 |
2006 |
10
🐜
|
|
🐜
|
A highly significant association between a COMT haplotype and schizophrenia.
21 auth.
S. Shifman,
Michal Bronstein,
M. Sternfeld,
Anne Pisanté-Shalom,
E. Lev-Lehman,
Abraham Weizman,
I. Reznik,
B. Spivak,
N. Grisaru,
L. Karp,
...
R. Schiffer,
M. Kotler,
R. Strous,
M. Swartz-Vanetik,
H. Knobler,
E. Shinar,
J. Beckmann,
B. Yakir,
N. Risch,
N. Zak,
A. Darvasi
|
9 |
2002 |
9
🐜
|
|
🐜
|
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
36 auth.
Maude Schneider,
M. Debbané,
A. Bassett,
E. Chow,
W. Fung,
M. V. D. van den Bree,
M. Owen,
K. Murphy,
Maria Niarchou,
W. Kates,
K. Antshel,
W. Fremont,
D. McDonald-McGinn,
R. Gur,
E. Zackai,
...
J. Vorstman,
Sasja N. Duijff,
P. Klaassen,
A. Swillen,
D. Gothelf,
T. Green,
Abraham Weizman,
Thérèse Van Amelsvoort,
L. Evers,
E. Boot,
V. Shashi,
S. Hooper,
C. Bearden,
M. Jalbrzikowski,
M. Armando,
S. Vicari,
D. Murphy,
O. Ousley,
L. Campbell,
T. Simon,
S. Eliez
|
9 |
2014 |
9
🐜
|
|
🐢
|
Enigma of the peripheral benzodiazepine receptor.
7 auth.
M. Gavish,
I. Bachman,
R. Shoukrun,
Y. Katz,
L. Veenman,
G. Weisinger,
...
Abraham Weizman
|
9 |
1999 |
9
🐢
|
|
🐬
|
Parents as the exclusive agents of change in the treatment of childhood obesity.
M. Golan,
Abraham Weizman,
A. Apter,
M. Fainaru
|
8 |
1998 |
8
🐬
|
|
🐢
|
Familial approach to the treatment of childhood obesity: conceptual mode.
M. Golan,
Abraham Weizman
|
8 |
2001 |
8
🐢
|
|
🐜
|
International Society for Bipolar Disorders Task Force on Suicide: meta‐analyses and meta‐regression of correlates of suicide attempts and suicide deaths in bipolar disorder
20 auth.
A. Schaffer,
E. Isometsä,
L. Tondo,
Doris H Moreno,
G. Turecki,
C. Reis,
F. Cassidy,
M. Sinyor,
J. Azorin,
L. Kessing,
...
Kyooseob Ha,
T. Goldstein,
Abraham Weizman,
A. Beautrais,
Y. Chou,
N. Diazgranados,
A. Levitt,
C. Zarate,
Z. Rihmer,
L. Yatham
|
8 |
2014 |
8
🐜
|
|
🐬
|
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O. Kaidanovich‐Beilin,
A. Milman,
Abraham Weizman,
C. Pick,
H. Eldar-Finkelman
|
8 |
2004 |
8
🐬
|
|
🐜
|
Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome.
8 auth.
T. Green,
D. Gothelf,
B. Glaser,
M. Debbané,
A. Frisch,
M. Kotler,
...
Abraham Weizman,
S. Eliez
|
8 |
2009 |
8
🐜
|
|
🐬
|
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials.
S. Grozinsky-Glasberg,
A. Fraser,
E. Nahshoni,
Abraham Weizman,
L. Leibovici
|
8 |
2006 |
8
🐬
|
|
🐢
|
Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change
M. Golan,
M. Fainaru,
Abraham Weizman
|
7 |
1998 |
7
🐢
|
|
🐜
|
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
12 auth.
D. Gothelf,
B. Falk,
P. Singer,
M. Kairi,
M. Phillip,
L. Zigel,
...
I. Poraz,
S. Frishman,
N. Constantini,
G. Zalsman,
Abraham Weizman,
A. Apter
|
7 |
2002 |
7
🐜
|
